99Tc nanocolloid sentinel node procedure in papillary thyroid carcinoma: Our mono-institutional experience on a large series of patients;La tecnica del linfonodo sentinella con 99Tc-nanocolloide nel carcinoma papillare della tiroide: La nostra esperienza monoistituzionale

Acta Otorhinolaryngologica Italica

Volumn 29, Issue 6, 2009, Pages 321-325

  Pelizzo, M R ^a   Toniato, A ^a   Sorgato, N ^a   Losi, A ^a   Torresan, F ^a   Boschin, I Merante ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cancer; Node metastases; Radiocolloid lymphoscintigraphy; Sentinel lymph node; Thyroid

Indexed keywords

DIAGNOSTIC AGENT; MACROSALB TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M NANOCOLLOID;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SENTINEL LYMPH NODE BIOPSY; THYROID TUMOR;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN; THYROID NEOPLASMS; YOUNG ADULT;

EID: 77952484036     PISSN: 0392100X     EISSN: 1827675X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Pasieka JL. Sentinel lymph node biopsy in the management of thyroid disease. Br J Surg 2001;88:321-2.
2. Pelizzo MR, Rubello D, Merante Boschin I, Piotto A, Pagetta C, Toniato A, et al. Contribution of SLN investigation with 99m Tc-nanocolloid in clinical staging of thyroid cancer: technical feasibility. Eur J Nucl Med Mol Imaging 2007;34:934-8.
3. Rubello D, Pelizzo MR, Al-Nahhas A, Salvatori M, O'Doherty MJ, Giuliano AE, et al. The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur J Surg Oncol 2006;32:917-21.
4. Rubello D, Nanni C, Merante Boschin I, Toniato A, Piotto A, Rampin L, et al. Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method? J Exp Clin Cancer Res 2006;25:483-6.
5. Boschin IM, Toniato A, Piotto A, Ide EC, Casara D, Guolo A, et al. 99Tc Nanocolloid sentinel node procedure in thyroid carcinoma. Langenbecks Arch Surg 2008;393:705-8.
6. Wiseman SM, Hicks WL Jr, Chu QD, Rigual NR. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg Oncol 2002;11:137-42.
7. Delbridge L. Sentinel lymph node biopsy for thyroid cancer: why bother? ANZ J Surg 2004;74:10-2.
8. Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288-92.
9. Gallowitsch HJ, Mikosch P, Kresnik E, Starlinger M, Lind P. Lymphoscintigraphy and gamma probe-guided surgery in papillary thyroid carcinoma: the sentinel lymph node concept in thyroid carcinoma. Clin Nucl Med 1999;24:744-6.
10. Rettenbacher L, Sungler P, Gmeiner D, Kassman H, Galvan G. Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma. Eur J Nucl Med 2000;27:1399-401.
11. Carcoforo P, Feggi L, Trasforini G, Lanzara S, Sortini D, Zulian V, et al. Use of preoperative lymphoscintigraphy and intraoperative gamma probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma. EJSO 2007;33:1075-80.
12. Chen SL, Iddings DM, Scheri RP, Bilchik AJ. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin 2006;56:292-309.
13. Rubello D, O'Doherty MJ. Sentinel lymph node biopsy in differentiated thyroid cancer: standard of care or experimental tool? Nucl Med Commun 2006;27:833-5.
14. Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63.
15. Noguchi M, Yamada H, Ohta N, Ishida T, Tajiri K, Fujii H, et al. Regional lymph node metastases in well-differentiated thyroid carcinoma. Int Surg 1987;72:100-3.
16. Ahuja S, Ernst H, Lenz K. Papillary thyroid carcinoma: occurrence and types of lymph node metastases. J Endocrinol Invest 1991;14:543-9.
17. Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 1996;172:692-4.
18. Gimm O, Rath FW, Dralle H. Pattern of lymph node metastases in papillary thyroid carcinoma. Br J Surg 1998;85:252-4.
19. Shaha AR. Management of the neck in thyroid cancer. Otolaryngol Clin North Am 1998;31:823-31.
20. Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002;26:22-8.
21. Mirallie E, Visset J, Sagan C, Hamy A, Le Bodic MF, Paineau J. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 1999;23:970-3.
22. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Official Report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991;117:601-5.
23. Robbins KT. Classification of neck dissection. Current concepts and future considerations. Otolaryngol Clin North Am 1998;31:639-55.
24. Voutilainen PE, Siironen P, Franssila KO, Sivula A, Haapiainen RK, Haglund CH. AMES, MACIS, and TNM prognostic classifications in papillary thyroid carcinoma. Anticancer Res 2003;23:4283-8.
25. Pasieka JL, Rotstein LE. Consensus conference on welldifferentiated thyroid cancer: a summary. Can J Surg 1993;36:298-301.
26. Rigual NR, Anderson GR, Loree TR, Wiseman S, Alrawi S, Stoler DL. Molecular prognosticators and genomic instability in papillary thyroid cancer. Laryngoscope 2005;115:1479-85.
27. Shaha AR. TNM classification of thyroid carcinoma. World J Surg 2007;31:879-87.
28. Grebe SK, Hay ID. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 1996;5:43-63.
29. Witte J, Schlotmann U, Simon D, Dotzenrath C, Ohmann C, Goretzki PE. Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis -- a meta-analysis. Zentralbl Chir 1997;122:259-65.
30. Mazzaferri EL, Jhiang SM. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
31. Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 2008;15:1518-22.
32. Dixon E, McKinnon G, Pasieka JL. Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 2000;24:1396-401.
33. Arch-Ferrer J, Valazquez D, Fajardo R, Gamboa-Domininguez A, Herrera MF. Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 2001;130:907-13.
34. Lee SK, Choi JH, Lim HI, Kim WW, Kim SM, Choe JH, et al. Sentinel lymph node biopsy in papillary thyroid cancer: comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer. Eur J Surg Oncol 2009;35:974-9.
35. Catarci M, Zaraca F, Angeloni R, Mancini B, de Filippo MG, Massa R, et al. Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid cancer. A pilot study. J Surg Oncol 2001;77:21-4.
36. Roh JL, Park CI. Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma. Cancer 2008;113:1527-31